Distribution characteristics and genomic epidemiology of carbapenem-resistant Acinetobacter baumannii

Authors

  • Ruixiang Luo Department of Laboratory Medicine, The People’s Hospital of Suzhou New District, Suzhou 215129, Jiangsu Province, China
  • Jinpei Lu Department of Laboratory Medicine, The Fifth People's Hospital of Zhuhai, Zhuhai 519055, Guangdong Province, China
  • Yu Nong Department of Laboratory Medicine, The People’s Hospital of Suzhou New District, Suzhou 215129, Jiangsu Province, China
  • Hong Zhang Department of Laboratory Medicine, The People’s Hospital of Suzhou New District, Suzhou 215129, Jiangsu Province, China
  • Minmin Tian Department of Laboratory Medicine, The People’s Hospital of Suzhou New District, Suzhou 215129, Jiangsu Province, China
  • Yufeng Wang Department of Laboratory Medicine, The People’s Hospital of Suzhou New District, Suzhou 215129, Jiangsu Province, China
  • Shan Huang Department of Laboratory Medicine, The People’s Hospital of Suzhou New District, Suzhou 215129, Jiangsu Province, China
  • Nannan Dai Department of Laboratory Medicine, The People’s Hospital of Suzhou New District, Suzhou 215129, Jiangsu Province, China
  • Yihua Wang Department of Pharmacy, The First Affiliated Hospital of Naval Medical University, Shanghai 200082, China

DOI:

https://doi.org/10.3855/jidc.20580

Keywords:

Acinetobacter baumannii, carbapenem, distribution, genomic epidemiology, resistance

Abstract

Introduction: Carbapenem-resistant Acinetobacter baumannii poses significant challenges in clinical settings due to rapid emergence and limited treatment options. This study aimed to investigate the distribution characteristics and genomic epidemiology of carbapenem-resistant A. baumannii in a regional healthcare context to identify novel trends and genetic determinants.

Methodology: A total of 120 clinically isolated strains of carbapenem-resistant A. baumannii were collected in our hospital from July 2021 to June 2023. Distribution characteristics were assessed based on infection sites. Whole genome sequencing was performed to profile resistance genes.

Results: The resistance rates of carbapenem-resistant A. baumannii to 15 antibiotics, such as tobramycin and amikacin, increased yearly during the three years (p < 0.05). Respiratory tract and urinary tract infections were dominant. Whole genome sequencing revealed high prevalence rates of β-lactamase genes (AmpC: 82.5%, OXA-23: 70.83%, IMP-1: 54.17%) and efflux system genes (adeB: 78.33%, adeJ: 93.33%, adeG: 90.00%).

Conclusions: Our study provides novel insights by identifying significant increases in antibiotic resistance and revealing critical genomic co-occurrence patterns of resistance genes in carbapenem-resistant A. baumannii. These findings enhance the understanding of resistance mechanisms and support targeted strategies for improved prevention, control, and monitoring of nosocomial infections.

Downloads

Published

2026-05-31

How to Cite

1.
Luo R, Lu J, Nong Y, Zhang H, Tian M, Wang Y, Huang S, Dai N, Wang Y (2026) Distribution characteristics and genomic epidemiology of carbapenem-resistant Acinetobacter baumannii. J Infect Dev Ctries 20:649–653. doi: 10.3855/jidc.20580

Issue

Section

Original Articles